Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease atrial fibrillation
Comorbidity C0034065|pulmonary embolism
Sentences 2
PubMedID- 23365716 Rivaroxaban has successfully met primary efficacy and safety endpoints in large, randomized phase iii trials across several indications, including: prevention of venous thromboembolism in orthopedic patients undergoing elective hip or knee replacement surgery; treatment of deep vein thrombosis and secondary prevention of deep vein thrombosis and pulmonary embolism; stroke prevention in patients with atrial fibrillation; and secondary prevention of acute coronary syndrome.
PubMedID- 22212132 Is atrial fibrillation associated with pulmonary embolism.

Page: 1